Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States.
- DOI
- 10.1038/s41523-026-00891-7
- Published
- 2026 Jan 23
- Container
- NPJ breast cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41523-026-00891-7,
title = {Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States.},
author = {Farrokhi P and Park L and Schmutz W and Thompson SL and Lam C and Bryan J and Stenehjem DD},
year = {2026},
journal = {NPJ breast cancer},
doi = {10.1038/s41523-026-00891-7},
url = {https://doi.org/10.1038/s41523-026-00891-7}
}RIS
TY - JOUR TI - Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States. AU - Farrokhi P AU - Park L AU - Schmutz W AU - Thompson SL AU - Lam C AU - Bryan J AU - Stenehjem DD PY - 2026 JO - NPJ breast cancer DO - 10.1038/s41523-026-00891-7 UR - https://doi.org/10.1038/s41523-026-00891-7 ER -
APA
P, F., L, P., W, S., SL, T., C, L., J, B., & DD, S. (2026). Racial differences in biomarkers, treatment, and outcomes in HR+/HER2- metastatic breast cancer in the United States.. NPJ breast cancer. https://doi.org/10.1038/s41523-026-00891-7
Source records
- pubmed · retrieved 2026-09-26T09:46:33.321Z